{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:26:44Z","timestamp":1790335604617,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,17]],"date-time":"2017-08-17T00:00:00Z","timestamp":1502928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Selective serotonin reuptake inhibitors (SSRIs) bind 5-HT transporters, leading to the accumulation of 5-HT and amelioration of depression. Although different mouse strains show varying sensitivity to SSRIs in mouse models of depression, the underlying mechanism of these strain differences remains unclear. Here, the SSRI citalopram dose-dependently reduced immobility time in both the FST and TST in DBA\/2J mice but not C57BL\/6J mice, whereas fluoxetine showed the opposite results. Paroxetine similarly reduced immobility time in both strains. The affinity of citalopram for the 5-HT transporter was 700-fold higher in DBA\/2J mice than in C57BL\/6J mice, whereas the affinity of fluoxetine was 100-fold higher in C57BL\/6J mice than in DBA\/2J mice. Furthermore, high citalopram concentrations were required for [<jats:sup>3<\/jats:sup>H]5-HT uptake in C57BL\/6J but not in DBA\/2J mouse cortical synaptosomes, whereas fluoxetine showed the opposite results. The effects of paroxetine on 5-HT transporter binding and synaptosomal 5-HT uptake were similar in the two strains. These results suggest that immobility duration depends on 5-HT transporter binding levels, which lead to apparent strain differences in immobility time in the FST and TST. Furthermore, differences in 5-HT transporter binding may cause variations in SSRI effects on behaviors.<\/jats:p>","DOI":"10.1038\/s41598-017-08953-4","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T13:52:14Z","timestamp":1502459534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function"],"prefix":"10.1038","volume":"7","author":[{"given":"Zeng-liang","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hua","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-na","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,17]]},"reference":[{"key":"8953_CR1","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan, V. & Nestler, E. J. The molecular neurobiology of depression. Nature \n                           455, 894\u2013902, doi:10.1038\/nature07455 (2008).","journal-title":"Nature"},{"key":"8953_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2006.12.005","volume":"30","author":"RC Shelton","year":"2007","unstructured":"Shelton, R. C. The molecular neurobiology of depression. The Psychiatric clinics of North America \n                           30, 1\u201311, doi:10.1016\/j.psc.2006.12.005 (2007).","journal-title":"The Psychiatric clinics of North America"},{"key":"8953_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s40263-016-0314-y","volume":"30","author":"M Zimmerman","year":"2016","unstructured":"Zimmerman, M. et al. Problems in the Descriptions of the Psychiatric Inclusion and Exclusion Criteria in Publications of Antidepressant Efficacy Trials: A Qualitative Review and Recommendations for Improved Clarity. CNS drugs \n                           30, 185\u2013191, doi:10.1007\/s40263-016-0314-y (2016).","journal-title":"CNS drugs"},{"key":"8953_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40279-015-0441-5","volume":"46","author":"B Stubbs","year":"2016","unstructured":"Stubbs, B. et al. Challenges Establishing the Efficacy of Exercise as an Antidepressant Treatment: A Systematic Review and Meta-Analysis of Control Group Responses in Exercise Randomised Controlled Trials. Sports medicine \n                           46, 699\u2013713, doi:10.1007\/s40279-015-0441-5 (2016).","journal-title":"Sports medicine"},{"key":"8953_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1126\/science.285.5428.763","volume":"285","author":"S Ramamoorthy","year":"1999","unstructured":"Ramamoorthy, S. & Blakely, R. D. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science \n                           285, 763\u2013766 (1999).","journal-title":"Science"},{"key":"8953_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.psychres.2010.07.039","volume":"186","author":"LH Muhonen","year":"2011","unstructured":"Muhonen, L. H. et al. Serotonin transporter polymorphism as a predictor for escitalopram treatment of major depressive disorder comorbid with alcohol dependence. Psychiatry research \n                           186, 53\u201357, doi:10.1016\/j.psychres.2010.07.039 (2011).","journal-title":"Psychiatry research"},{"key":"8953_CR7","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/npp.2015.335","volume":"41","author":"AG Nackenoff","year":"2016","unstructured":"Nackenoff, A. G., Moussa-Tooks, A. B., McMeekin, A. M., Veenstra-VanderWeele, J. & Blakely, R. D. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology \n                           41, 1733\u20131741, doi:10.1038\/npp.2015.335 (2016).","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"8953_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0006-3223(98)00124-3","volume":"44","author":"RD Blakely","year":"1998","unstructured":"Blakely, R. D. et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biological psychiatry \n                           44, 169\u2013178 (1998).","journal-title":"Biological psychiatry"},{"key":"8953_CR9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1242\/jeb.196.1.263","volume":"196","author":"RD Blakely","year":"1994","unstructured":"Blakely, R. D., De Felice, L. J. & Hartzell, H. C. Molecular physiology of norepinephrine and serotonin transporters. The Journal of experimental biology \n                           196, 263\u2013281 (1994).","journal-title":"The Journal of experimental biology"},{"key":"8953_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0169-328X(96)00172-6","volume":"43","author":"AS Chang","year":"1996","unstructured":"Chang, A. S. et al. Cloning and expression of the mouse serotonin transporter. Brain research. Molecular brain research \n                           43, 185\u2013192 (1996).","journal-title":"Brain research. Molecular brain research"},{"key":"8953_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1073\/pnas.0809449106","volume":"106","author":"AM Carneiro","year":"2009","unstructured":"Carneiro, A. M. et al. Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proceedings of the National Academy of Sciences of the United States of America \n                           106, 2047\u20132052, doi:10.1073\/pnas.0809449106 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"8953_CR12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","volume":"29","author":"JF Cryan","year":"2005","unstructured":"Cryan, J. F., Mombereau, C. & Vassout, A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neuroscience and biobehavioral reviews \n                           29, 571\u2013625, doi:10.1016\/j.neubiorev.2005.03.009 (2005).","journal-title":"Neuroscience and biobehavioral reviews"},{"key":"8953_CR13","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt, R. D., Bertin, A. & Jalfre, M. Behavioral despair in mice: a primary screening test for antidepressants. Archives internationales de pharmacodynamie et de therapie \n                           229, 327\u2013336 (1977).","journal-title":"Archives internationales de pharmacodynamie et de therapie"},{"key":"8953_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1017\/S146114571400073X","volume":"17","author":"M Tang","year":"2014","unstructured":"Tang, M. et al. Immobility responses between mouse strains correlate with distinct hippocampal serotonin transporter protein expression and function. The international journal of neuropsychopharmacology \n                           17, 1737\u20131750, doi:10.1017\/S146114571400073X (2014).","journal-title":"The international journal of neuropsychopharmacology"},{"key":"8953_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s002130050181","volume":"129","author":"C Sanchez","year":"1997","unstructured":"Sanchez, C. & Meier, E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology \n                           129, 197\u2013205 (1997).","journal-title":"Psychopharmacology"},{"key":"8953_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.euroneuro.2015.01.005","volume":"25","author":"ZL Jin","year":"2015","unstructured":"Jin, Z. L. et al. The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology \n                           25, 544\u2013556, doi:10.1016\/j.euroneuro.2015.01.005 (2015).","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"key":"8953_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00213-002-1335-4","volume":"166","author":"DJ David","year":"2003","unstructured":"David, D. J., Renard, C. E., Jolliet, P., Hascoet, M. & Bourin, M. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology \n                           166, 373\u2013382, doi:10.1007\/s00213-002-1335-4 (2003).","journal-title":"Psychopharmacology"},{"key":"8953_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2008.07.005","volume":"592","author":"Y Sugimoto","year":"2008","unstructured":"Sugimoto, Y. et al. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. European journal of pharmacology \n                           592, 116\u2013122, doi:10.1016\/j.ejphar.2008.07.005 (2008).","journal-title":"European journal of pharmacology"},{"key":"8953_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12264-010-0323-7","volume":"26","author":"H Yan","year":"2010","unstructured":"Yan, H. et al. Behavioral animal models of depression. Neuroscience bulletin \n                           26, 327\u2013337, doi:10.1007\/s12264-010-0323-7 (2010).","journal-title":"Neuroscience bulletin"},{"key":"8953_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/266730a0","volume":"266","author":"RD Porsolt","year":"1977","unstructured":"Porsolt, R. D., Le Pichon, M. & Jalfre, M. Depression: a new animal model sensitive to antidepressant treatments. Nature \n                           266, 730\u2013732 (1977).","journal-title":"Nature"},{"key":"8953_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/hipo.22242","volume":"24","author":"M Tang","year":"2014","unstructured":"Tang, M. et al. Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression. Hippocampus \n                           24, 493\u2013501, doi:10.1002\/hipo.22242 (2014).","journal-title":"Hippocampus"},{"key":"8953_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002130100694","volume":"155","author":"I Lucki","year":"2001","unstructured":"Lucki, I., Dalvi, A. & Mayorga, A. J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology \n                           155, 315\u2013322 (2001).","journal-title":"Psychopharmacology"},{"key":"8953_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroscience.2011.08.056","volume":"197","author":"R Ye","year":"2011","unstructured":"Ye, R. & Blakely, R. D. Natural and engineered coding variation in antidepressant-sensitive serotonin transporters. Neuroscience \n                           197, 28\u201336, doi:10.1016\/j.neuroscience.2011.08.056 (2011).","journal-title":"Neuroscience"},{"key":"8953_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbr.2005.10.019","volume":"168","author":"FR Hinojosa","year":"2006","unstructured":"Hinojosa, F. R. et al. Evaluation of two genetic animal models in behavioral tests of anxiety and depression. Behavioural brain research \n                           168, 127\u2013136, doi:10.1016\/j.bbr.2005.10.019 (2006).","journal-title":"Behavioural brain research"},{"key":"8953_CR25","first-page":"895","volume":"25","author":"A Daniele","year":"2011","unstructured":"Daniele, A. et al. Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant. In vivo \n                           25, 895\u2013901 (2011).","journal-title":"In vivo"},{"key":"8953_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2004.04.008","volume":"155","author":"S Pothion","year":"2004","unstructured":"Pothion, S., Bizot, J. C., Trovero, F. & Belzung, C. Strain differences in sucrose preference and in the consequences of unpredictable chronic mild stress. Behavioural brain research \n                           155, 135\u2013146, doi:10.1016\/j.bbr.2004.04.008 (2004).","journal-title":"Behavioural brain research"},{"key":"8953_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-4-35","volume":"4","author":"TM Kerr","year":"2013","unstructured":"Kerr, T. M. et al. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Molecular autism \n                           4, 35, doi:10.1186\/2040-2392-4-35 (2013).","journal-title":"Molecular autism"},{"key":"8953_CR28","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11689-009-9020-0","volume":"1","author":"J Veenstra-Vanderweele","year":"2009","unstructured":"Veenstra-Vanderweele, J. et al. Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. Journal of neurodevelopmental disorders \n                           1, 158\u2013171, doi:10.1007\/s11689-009-9020-0 (2009).","journal-title":"Journal of neurodevelopmental disorders"},{"key":"8953_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/14992027.2016.1198966","volume":"55","author":"M Durai","year":"2016","unstructured":"Durai, M. & Searchfield, G. Anxiety and depression, personality traits relevant to tinnitus: A scoping review. International journal of audiology \n                           55, 605\u2013615, doi:10.1080\/14992027.2016.1198966 (2016).","journal-title":"International journal of audiology"},{"key":"8953_CR30","doi-asserted-by":"publisher","unstructured":"Glue, P. et al. Comments on Cooper et al.\u2018s review on strategies to mitigate dissociative and psychotomimetic effects from ketamine when used as a fast-acting antidepressant. The world journal of biological psychiatry: the official journal of the World Federation of Societies of Biological Psychiatry, 1, doi:10.1080\/15622975.2016.1181782 (2016).","DOI":"10.1080\/15622975.2016.1181782"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08953-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08953-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T08:50:30Z","timestamp":1671785430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-08953-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,17]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["8953"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-08953-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,17]]},"assertion":[{"value":"9 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"8631"}}